Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Postprandial lipids in adolescents with obesity and insulin resistance
EF 2020-21
Résumé
Adolescents with obesity have an increased risk for developing cardiovascular disease (CVD) and Type 2 Diabetes (T2D), where postprandial dyslipidemia is an important risk factor. Postprandial dyslipidemia refers to abnormal lipid metabolism in the non-fasted state. This primarily occurs due to the overproduction of lipid carriers, termed lipoproteins, from the liver. The accumulation of certain lipoproteins is associated with both obesity and insulin resistance (IR) and facilitates the formation of plaque on arterial walls, a risk factor for CVD, in part by promoting an inflammatory state. Indeed, the state of systemic inflammation induced by obesity is associated with the development of IR and other obesity-related morbidities. Furthermore, the regulation of lipid metabolism involves critical hormones, known as glucagon-like peptides, and bile acids. A recent study from our group uncovered the postprandial dysregulation of these metabolites in adolescents with obesity and IR. Specifically, blood samples were taken at baseline and for several hours post-ingestion of a high-fat meal in adolescents with normal weight and with obesity and IR. Through further analysis of these samples, the proposed research aims to understand the postprandial dysregulation of inflammatory and metabolic markers in adolescents with obesity and IR, and their potential role in the development of postprandial dyslipidemia. In addition, we seek to determine the clinical utility of these novel biomarkers in predicting the subclinical progression to T2D. Postprandial dyslipidemia is a common complication of obesity and IR, and the proposed work will assist in uncovering the contributing role that inflammatory and metabolic markers may play in the dysregulation of lipid and lipoprotein metabolism.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449710
Name
Wilson Siobhan M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Postprandial lipids in adolescents with obesity and insulin resistance
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiovascular Disease; Diabetes; Dyslipidemia; Endocrinology; Inflammation; Insulin Resistance; Metabolic Syndrome; Metabolism; Obesity; Pediatrics
Abstract
Adolescents with obesity have an increased risk for developing cardiovascular disease (CVD) and Type 2 Diabetes (T2D), where postprandial dyslipidemia is an important risk factor. Postprandial dyslipidemia refers to abnormal lipid metabolism in the non-fasted state. This primarily occurs due to the overproduction of lipid carriers, termed lipoproteins, from the liver. The accumulation of certain lipoproteins is associated with both obesity and insulin resistance (IR) and facilitates the formation of plaque on arterial walls, a risk factor for CVD, in part by promoting an inflammatory state. Indeed, the state of systemic inflammation induced by obesity is associated with the development of IR and other obesity-related morbidities. Furthermore, the regulation of lipid metabolism involves critical hormones, known as glucagon-like peptides, and bile acids. A recent study from our group uncovered the postprandial dysregulation of these metabolites in adolescents with obesity and IR. Specifically, blood samples were taken at baseline and for several hours post-ingestion of a high-fat meal in adolescents with normal weight and with obesity and IR. Through further analysis of these samples, the proposed research aims to understand the postprandial dysregulation of inflammatory and metabolic markers in adolescents with obesity and IR, and their potential role in the development of postprandial dyslipidemia. In addition, we seek to determine the clinical utility of these novel biomarkers in predicting the subclinical progression to T2D. Postprandial dyslipidemia is a common complication of obesity and IR, and the proposed work will assist in uncovering the contributing role that inflammatory and metabolic markers may play in the dysregulation of lipid and lipoprotein metabolism.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wilson, Siobhan M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~